ArticleOncology letters2018

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

Bicheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.